Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

May 25, 2018

Study Completion Date

May 25, 2018

Conditions

Healthy Subjects

Interventions

DRUG

Perampanel

Oral Tablet

Trial Locations (1)

Eisai Trial Site, Beijing

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT03424564 - Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects | Biotech Hunter | Biotech Hunter